UPDATE 1-Novartis says 3 executives to leave after GSK, Lilly deals
October 08, 2014 at 03:41 AM EDT
ZURICH, Oct 8 (Reuters) - Swiss drugmaker Novartis AG said three members of its executive committee would leave the company following the completion of transactions with GlaxoSmithKline and Eli Lilly to divest three units.